Rohan T. Baker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rohan T. Baker has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- David Andrew Jans
Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia
2 shared publications Grant R. Sutherland
From the ‡Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, G. P. O. Box 334, Canberra, Australian Capital Territory 2601, Australia and ¶Centre for Medical Genetics, Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide, South Australia 5006, Australia
2 shared publications- Tatiana A. Soboleva
The Australian National University
2 shared publications Xiao-Wen Wang
From the ‡Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, G. P. O. Box 334, Canberra, Australian Capital Territory 2601, Australia and ¶Centre for Medical Genetics, Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide, South Australia 5006, Australia
2 shared publicationsAnn‐Maree Catanzariti
Molecular Genetics Group, Division of Molecular Medicine, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 0200, Australia
1 shared publicationErica Woollatt
1 shared publication
Latest Publications
- Open Access
- 21 October 2008
- Published by Springer Nature in BMC Biochemistry
- Vol. 9 (S1) , S3
Deubiquitylating enzymes and disease
Deubiquitylating enzymes (DUBs) can hydrolyze a peptide, amide, ester or thiolester bond at the C-terminus of UBIQ (ubiquitin), including the post-translationally formed branched peptide bonds in mono- or multi-ubiquitylated conjugates. DUBs thus have the potential to regulate any UBIQ-mediated cellular process, the two best characterized being proteolysis and protein trafficking. Mammals contain some 80–90 DUBs in five different subfamilies, only a handful of which have been characterized with respect to the proteins that they interact with and deubiquitylate. Several other DUBs have been implicated in various disease processes in which they are changed by mutation, have altered expression levels, and/or form part of regulatory complexes. Specific examples of DUB involvement in various diseases are presented. While no specific drugs targeting DUBs have yet been described, sufficient functional and structural information has accumulated in some cases to allow their rapid development. Publication history: Republished from Current BioData's Targeted Proteins database (TPdb; http://www.targetedproteinsdb.com).
- 21 October 2008
- Published by Springer Nature in BMC Biochemistry
- Vol. 9 (S1) , S3
Open AccessDeubiquitylating enzymes and disease
Deubiquitylating enzymes (DUBs) can hydrolyze a peptide, amide, ester or thiolester bond at the C-terminus of UBIQ (ubiquitin), including the post-translationally formed branched peptide bonds in mono- or multi-ubiquitylated conjugates. DUBs thus have the potential to regulate any UBIQ-mediated cellular process, the two best characterized being proteolysis and protein trafficking. Mammals contain some 80–90 DUBs in five different subfamilies, only a handful of which have been characterized with respect to the proteins that they interact with and deubiquitylate. Several other DUBs have been implicated in various disease processes in which they are changed by mutation, have altered expression levels, and/or form part of regulatory complexes. Specific examples of DUB involvement in various diseases are presented. While no specific drugs targeting DUBs have yet been described, sufficient functional and structural information has accumulated in some cases to allow their rapid development. Publication history: Republished from Current BioData's Targeted Proteins database (TPdb; http://www.targetedproteinsdb.com).
- Open Access
- 1 January 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (1) , 745-752
Nuclear-Cytoplasmic Shuttling of the Oncogenic Mouse UNP/USP4 Deubiquitylating Enzyme
- 1 January 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (1) , 745-752
Open AccessNuclear-Cytoplasmic Shuttling of the Oncogenic Mouse UNP/USP4 Deubiquitylating Enzyme
- 1 May 2004
- Published by Wiley in Protein Science
- Vol. 13 (5) , 1331-1339
An efficient system for high‐level expression and easy purification of authentic recombinant proteins
Expression of recombinant proteins as fusions to the eukaryotic protein ubiquitin has been found to significantly increase the yield of unstable or poorly expressed proteins. The benefit of this technique is further enhanced by the availability of naturally occurring deubiquitylating enzymes, which remove ubiquitin from the fusion product. However, the versatility of the system has been constrained due to the lack of a robust, easily purified deubiquitylating enzyme. Here we report the development of an efficient expression system, utilizing the ubiquitin fusion technique, which allows convenient high yield and easy purification of authentic protein. An Escherichia coli vector (pHUE) was constructed for the expression of proteins as histidine‐tagged ubiquitin fusions, and a histidine‐tagged deubiquitylating enzyme to cleave these fusions was expressed and purified. The expression system was tested using several proteins varying in size and complexity. These results indicate that this procedure will be suitable for the expression and rapid purification of a broad range of proteins and peptides, and should be amenable to high‐throughput applications.
- 1 May 2004
- Published by Wiley in Protein Science
- Vol. 13 (5) , 1331-1339
An efficient system for high‐level expression and easy purification of authentic recombinant proteins
Expression of recombinant proteins as fusions to the eukaryotic protein ubiquitin has been found to significantly increase the yield of unstable or poorly expressed proteins. The benefit of this technique is further enhanced by the availability of naturally occurring deubiquitylating enzymes, which remove ubiquitin from the fusion product. However, the versatility of the system has been constrained due to the lack of a robust, easily purified deubiquitylating enzyme. Here we report the development of an efficient expression system, utilizing the ubiquitin fusion technique, which allows convenient high yield and easy purification of authentic protein. An Escherichia coli vector (pHUE) was constructed for the expression of proteins as histidine‐tagged ubiquitin fusions, and a histidine‐tagged deubiquitylating enzyme to cleave these fusions was expressed and purified. The expression system was tested using several proteins varying in size and complexity. These results indicate that this procedure will be suitable for the expression and rapid purification of a broad range of proteins and peptides, and should be amenable to high‐throughput applications.
- 1 January 2003
- Published by Xia & He Publishing in Gene Expression
- Vol. 11 (3) , 163-179
Gene Structure, Alternate Splicing, Tissue Distribution, Cellular Localization, and Developmental Expression Pattern of Mouse Deubiquitinating Enzyme Isoforms Usp2-45 and Usp2-69
We have identified a novel mouse gene, Usp2, encoding two ubiquitin-specific proteases (USPs) due to alternate splicing of 5′ exons. Usp2-45 consists of 396 amino acids (45.2 kDa), while Usp2-69 is 619 amino acids (69.5 kDa). Usp2-69 results from the splicing of different combinations of untranslated 5′ exons (1A, 1B, 1C) onto exon 1D and the 40-kDa catalytic core (exons 3–13), while Usp2-45 has exon 2 spliced onto the core. The catalytic core contains the highly conserved motifs of the UBP family of deubiquitinating enzymes. We can find no evidence for a reported 41-kDa isoform (UBP41) in any sequence databases. Usp2-69 is able to form a complex with Usp2-45 and with itself. Antibodies raised against the catalytic core recognized a 69-kDa protein, but did not detect a 45-kDa protein in mouse tissues. Using Northern blot, Western blot, and immunohistochemistry, Usp2 expression was observed in many adult and embryonic tissues including testis, heart, skeletal muscle, diaphragm, brain, kidney, liver, pancreas, lung, and skin. Both Usp2 isoforms were localized to the cytoplasm when overexpressed in COS-7 and NIH3T3 cells. The Usp2 expression pattern indicates that this protein might be involved in specific processes in different types of cells, especially those that are differentiating, and that its function is not restricted to a development of a particular organ.
- 1 January 2003
- Published by Xia & He Publishing in Gene Expression
- Vol. 11 (3) , 163-179
Gene Structure, Alternate Splicing, Tissue Distribution, Cellular Localization, and Developmental Expression Pattern of Mouse Deubiquitinating Enzyme Isoforms Usp2-45 and Usp2-69
We have identified a novel mouse gene, Usp2, encoding two ubiquitin-specific proteases (USPs) due to alternate splicing of 5′ exons. Usp2-45 consists of 396 amino acids (45.2 kDa), while Usp2-69 is 619 amino acids (69.5 kDa). Usp2-69 results from the splicing of different combinations of untranslated 5′ exons (1A, 1B, 1C) onto exon 1D and the 40-kDa catalytic core (exons 3–13), while Usp2-45 has exon 2 spliced onto the core. The catalytic core contains the highly conserved motifs of the UBP family of deubiquitinating enzymes. We can find no evidence for a reported 41-kDa isoform (UBP41) in any sequence databases. Usp2-69 is able to form a complex with Usp2-45 and with itself. Antibodies raised against the catalytic core recognized a 69-kDa protein, but did not detect a 45-kDa protein in mouse tissues. Using Northern blot, Western blot, and immunohistochemistry, Usp2 expression was observed in many adult and embryonic tissues including testis, heart, skeletal muscle, diaphragm, brain, kidney, liver, pancreas, lung, and skin. Both Usp2 isoforms were localized to the cytoplasm when overexpressed in COS-7 and NIH3T3 cells. The Usp2 expression pattern indicates that this protein might be involved in specific processes in different types of cells, especially those that are differentiating, and that its function is not restricted to a development of a particular organ.
- Open Access
- 1 September 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (38) , 26878-26884
Characterization and Chromosomal Localization of USP3, a Novel Human Ubiquitin-specific Protease
- 1 September 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (38) , 26878-26884
Open AccessCharacterization and Chromosomal Localization of USP3, a Novel Human Ubiquitin-specific Protease
- 1 October 1996
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 7 (5) , 541-546
Protein expression using ubiquitin fusion and cleavage
- 1 October 1996
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 7 (5) , 541-546
Protein expression using ubiquitin fusion and cleavage